학술논문
Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial
Document Type
Article
Author
Rosu, L.; Tomeny, E.M.; Squire, S.B.; Worrall, E.; Madan, J.J.; Muniyandi, M.; Narendran, G.; Nidoi, J.; Kirenga, B.; Girma, M.; Vilc, V.; Tudor, E.; Bindroo, P.; Bhatnagar, A.K.; Dhandhukiya, R.; Solanki, R.; Bayissa, A.K.; Meressa, D.; Meredith, S.K.; Nunn, A.J.; Bronson, G.; Rusen, I.D.; Ahmad, S.; Alexandru, S.; Bellenger, K.; Bulga, T.G.; Cook, C.; Crudu, V.; Deborah, B.; Dodds, W.; Gebreegziabher, B.A.; Goodall, R.L.; Gupta, P.; Gurumurthy, M.; Langley, I.; Nalunjogi, J.; Khan, S.; Krishnan, S.; Kumar, S.; Lesosky, M.; Macari, M.; Makwana, M.; Murphy, B.; Murugesan, R.P.; Patel, V.; Pirlog, I.; Rauchenberger, M.; Sanders, K.; Singh, R.; Subramani, S.; Teferi, M.; Tegegn, N.A.; Velmurugan, A.B.; Whitney, J.
Source
In: The Lancet Global Health . (The Lancet Global Health, February 2023, 11(2):e265-e277)
Subject
Language
English
ISSN
2214109X